Live tape
Top 8, mentions 7d10,771GOOGL2,061 mentions▲ +0.04SNDK1,523 mentions▲ +0.11SPCX1,494 mentions▲ +0.08NBIS1,420 mentions▲ +0.09HTZ1,232 mentions▲ +0.10NVDA1,187 mentions▲ +0.08META1,015 mentions▲ +0.03MSFT839 mentions▲ +0.06

Equity · Healthcare

IMNM

Immunome, Inc. · NasdaqCM

$22.31 +0.52% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 40 sessions
$25.0 $17.5 20 May 17 Jul

The line runs $22 on 20 May through $22.31 on 17 July, on a scale from $17.5 to $25.0. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of IMNM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 40 sessions over that window: $22 on 20 May 2026 through $22.31 on 17 July 2026.

Market cap $2.5B
52-week range $8 – $27
Avg volume 333.7K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

IMNM insider trades

SEC Form 4 · last 90 days · newest reported trade 12 Aug 2026
Open-market buys 1
Open-market sells 15
Net sold $15.68M
Non-trade filings 12
Date Insider Type Shares Value
12 Aug 2026 Barchas Isaac Director Sell 11,048 $301K
11 Aug 2026 Barchas Isaac Director Sell 62,291 $1.63M
10 Aug 2026 Barchas Isaac Director Sell 10,125 $264K
07 Aug 2026 Barchas Isaac Director Sell 15,248 $397K
06 Aug 2026 Barchas Isaac Director Sell 20,840 $543K
04 Aug 2026 Horn Kinney CHIEF BUSINESS OFFICER Sell 90,616 $2.27M
07 Jul 2026 Barchas Isaac Director Sell 16,906 $409K
07 Jul 2026 Horn Kinney CHIEF BUSINESS OFFICER Sell 1,092 $27K
06 Jul 2026 Barchas Isaac Director Sell 83,094 $2.00M
02 Jul 2026 Barchas Isaac Director Sell 100,000 $2.26M
02 Jul 2026 Lechleider Robert Chief Medical Officer Sell 55,000 $1.24M
30 Jun 2026 Barchas Isaac Director Sell 101,050 $2.13M

Showing the 12 most recent of 16 open-market trades in this window. The figures above count all of them.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
04 Aug 2026 Horn Kinney CHIEF BUSINESS OFFICER Option exercise 90,616 $1.08M
23 Jul 2026 Higgins Jack Chief Scientific Officer Award 38,250
23 Jul 2026 Horn Kinney CHIEF BUSINESS OFFICER Award 31,250
23 Jul 2026 SIEGALL CLAY B President and CEO Award 180,000
23 Jul 2026 Stoneman Sandra G. CHIEF LEGAL OFFICER & GC Award 38,250
23 Jul 2026 Rosett Max Chief Financial Officer Award 47,250
23 Jul 2026 Lechleider Robert Chief Medical Officer Award 54,000
23 Jul 2026 Tsai Philip Chief Technical Officer Award 38,250
07 Jul 2026 Horn Kinney CHIEF BUSINESS OFFICER Option exercise 1,092 $14K
02 Jul 2026 Lechleider Robert Chief Medical Officer Option exercise 55,000 $480K
25 Jun 2026 Lechleider Robert Chief Medical Officer Option exercise 55,000 $480K
15 Jun 2026 Rosett Max Chief Financial Officer Option exercise 60,000 $63K

IMNM reported financials

SEC EDGAR XBRL

IMNM reported revenue of $6.9M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$212.4M.

Figure Reported Period
Revenue $6.9M 31 Dec 2025 fiscal year
Net income −$212.4M 31 Dec 2025 fiscal year
Diluted EPS −$2.43 31 Dec 2025 fiscal year
Total assets $565.4M 30 Jun 2026 at period end
Total equity $525.1M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

IMNM earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.65 —
31 Mar 2026 Q1 2026 $-0.48 —
31 Dec 2025 FY 2025 $-2.43 $7M
30 Sep 2025 Q3 2025 $-0.65 —
30 Jun 2025 Q2 2025 $-0.50 $4M
31 Mar 2025 Q1 2025 $-0.52 $3M
31 Dec 2024 FY 2024 $-5.00 $9M
30 Sep 2024 Q3 2024 $-0.78 $3M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

IMNM institutional holders

SEC Form 13F

6 of the 45 institutional funds we track reported a IMNM position for the quarter ended 30 Jun 2026 — a combined $22.6M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Marshall Wace Trimmed −66.2% shares 500,537 $10.6M
Renaissance Technologies Added +264.4% shares 251,102 $5.3M
Citadel Advisors Added +179.4% shares 224,079 $4.7M
Baker Bros. Advisors New position 55,306 $1.2M
Two Sigma Investments New position 23,941 $507K
AQR Capital Management Trimmed −37.1% shares 11,780 $250K
Balyasny Asset Management Exited
Millennium Management Exited

Source: SEC EDGAR 13F filings

IMNM fails-to-deliver

SEC CNS data

On 31 Jul 2026, 347 shares of IMNM failed to deliver (about $8K).

Settlement date Shares failed Notional % of shares out
31 Jul 2026 347 $8K <0.001%
27 Jul 2026 522 $12K <0.001%
23 Jul 2026 4 $92 <0.001%
22 Jul 2026 265 $6K <0.001%
20 Jul 2026 993 $22K 0.001%
09 Jul 2026 4,107 $99K 0.004%
06 Jul 2026 794 $19K 0.001%

Source: SEC fails-to-deliver (CNS) data